Supernus Pharmaceuticals
SUPN
SUPN
214 hedge funds and large institutions have $951M invested in Supernus Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 69 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
12% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 26
0% more funds holding
Funds holding: 213 → 214 (+1)
Holders
214
Holding in Top 10
6
Calls
$4.27M
Puts
$3.34M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$15.5M | |
| 3 | +$9.6M | |
| 4 |
Bank of New York Mellon
New York
|
+$8.63M |
| 5 |
Millennium Management
New York
|
+$8.06M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$8.26M | |
| 3 | -$5.69M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$5.64M |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$5.01M |